BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37506986)

  • 1. TCAF2 is associated with the immune microenvironment, promotes pathogenesis, and impairs prognosis in glioma.
    Li Y; Li J; Chen H; Lu B; Lu F; Chen H; Liu H; Qian C
    Gene; 2023 Oct; 883():147667. PubMed ID: 37506986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCAF2 drives glioma cellular migratory/invasion properties through STAT3 signaling.
    Yun D; Liang J; Wang X; Fan J; Wang X; Li J; Ren X; Liu J; Ren X; Zhang H; Shang G; Jin W; Chen L; Li T; Zhang C; Yu S; Yang X
    Mol Cell Biochem; 2023 Nov; ():. PubMed ID: 38019450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Prognostic Analysis of Immune Implication Value and Oxidative Stress Significance of NECAP2 in Low-Grade Glioma.
    Lu Z; Chen Y; Chen S; Zhu X; Wang C; Wang Z; Yao Q
    Oxid Med Cell Longev; 2022; 2022():1494520. PubMed ID: 36531205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
    Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
    Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis.
    Zhang S; Guo Y; Hu Y; Gao X; Bai F; Ding Q; Hou K; Wang Z; Sun X; Zhao H; Qu Z; Xu Q
    Front Immunol; 2023; 14():1242972. PubMed ID: 37809064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCAF2 in Pericytes Promotes Colorectal Cancer Liver Metastasis via Inhibiting Cold-Sensing TRPM8 Channel.
    Li X; Qi Q; Li Y; Miao Q; Yin W; Pan J; Zhao Z; Chen X; Yang F; Zhou X; Huang M; Wang C; Deng L; Huang D; Qi M; Fan S; Zhang Y; Qiu S; Deng W; Liu T; Chen M; Ye W; Zhang D
    Adv Sci (Weinh); 2023 Oct; 10(30):e2302717. PubMed ID: 37635201
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma.
    Zhao L; Song C; Li Y; Yuan F; Zhao Q; Dong H; Liu B
    Genomics; 2023 May; 115(3):110602. PubMed ID: 36907429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma.
    Luo H; Tao C; Long X; Huang K; Zhu X
    Aging (Albany NY); 2021 Jun; 13(12):16198-16218. PubMed ID: 34114970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
    Qi Y; Chen D; Lu Q; Yao Y; Ji C
    Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of m
    Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
    Front Immunol; 2022; 13():955848. PubMed ID: 36203569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
    Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
    J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma.
    Liao G; Zhang M; Wang C
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3485-3494. PubMed ID: 35951089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.
    Li Y; Deng G; Qi Y; Zhang H; Gao L; Jiang H; Ye Z; Liu B; Chen Q
    Med Sci Monit; 2020 Aug; 26():e924054. PubMed ID: 32843610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
    Li J; Zhang Y; Qu Z; Ding R; Yin X
    Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.